Prognostic nutritional index predicts outcomes in hepatocellular carcinoma treated with atezolizumab and bevacizumab - EurekAlert!
Alliance presents results from phase III ATOMIC trial combining atezolizumab with chemotherapy for patients with stage III dMMR colon cancer at ASCO 2025 - EurekAlert!
